<img src="https://ml.globenewswire.com/Resource/Download/5a33b17c-e545-48d8-b797-832cf8e4372c?size=2" nborder="0" align="left" hspace="5" vspace="5" title="Cytek Logo - Color.jpg" alt="Cytek Biosciences, Inc."/>FREMONT, Calif., June 10, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that the company will be participating in the upcoming Singular Research’s Las Vegas Invitational Conference taking place June 14-16, 2026. Cytek management is scheduled to participate in a presentation on Monday, June 15th at 11:00 a.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: <a href="https://www.globenewswire.com/Tracker?data=Nu5KZ_BeBtfMovKrkh-nBPK4c3svh6B3omhTYODDb1R2DlQouJidU10zrYuTXkdOvYSc6Yk8jnQGH0Mc79NSAUCfqsuOR8ozliAc3_fV5M4=" rel="nofollow" target="_blank" title="investors.cytekbio.com">investors.cytekbio.com</a>. About Cytek Biosciences, Inc. Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling™ (FSP®) technology. Cytek’s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek’s platform includes: its core FSP instruments, the Cytek Aurora™, Northern Lights™, Cytek Aurora™ CS and Cytek Aurora™ Evo systems; the Cytek Orion™ reagent cocktail preparation system; the Enhanced Small Particle™ (ESP™) detection technology; the flow cytometers and imaging products under the Amnis® and Guava® brands; and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe. More information about the company and its products is available at <a href="https://www.globenewswire.com/Tracker?data=-Adib9CmFvXWHpj-BTSfyY3yrr7dr_SHsVadLHCdirnTWJEkFOx9U9iGpPhy4sGzN95j0qeGdV55wHmIhQumgU89oTmlF0TOKU6nQ2ts49bko42hbW0gJ2fN4iq566iLa5ViSEqUh7e8S4sg0L4bGwLCYR2TnAzH41dd2IyGByc129fbX8SBXRbl7dq0pbBCe-6bCs1ohdAKzO_r0pWa6Tpmj--EKISRXDQ1M8peiJ2SxMTX2oc3gwkiIEKFJLa9rNagny3YQJZPlq6sw---fXvGwhbluyh-I9-y5OC4QyFvuHOFn37HKTQIRtOcOCL4IYlcZCek3mx3Xr8lz8FGys5Vr-gEMrl3e1VOhnJgtqaUzK8_sWnK2Y5_2YWJ0b0Y6OIcHt4W68lHvkrKVsk-YEOZkmi4T-HeqltjnKD0VWT_jo69xLDHaS_dsL9BE40itzdfOAFo3vqK6tMNJ9ffsclRn-nGg85ZVUQ0Y0rzS9YeCy3RO4yVkQX1Uiz3MO16qkrjTibCPhQ9Gk4KoEVxLnYoboQgHK267Cwiaq4bWb-xFGjPmiXbEuZnDQwg0lY81RCR9QeKogTpj5RKTYVq4obpxSG-o0ariH-KG_BsbnllLqrbw7EJ2RCWutAuUwD3HpqxHCvbNar2YEri1NBCDQ==" rel="nofollow" target="_blank" title="www.cytekbio.com">www.cytekbio.com</a>. Cytek’s products are for research use only and not for use in diagnostic procedures (other than Cytek’s Northern Lights-CLC system and certain reagents, which are available for clinical use only in China and the European Union). Cytek, Full Spectrum Profiling, FSP, Cytek Aurora, Northern Lights, Enhanced Small Particle, ESP, Cytek Orion, Amnis and Guava are trademarks of Cytek Biosciences, Inc. In addition to filings with the Securities and Exchange Commission (SEC), press releases, public conference calls and webcasts, Cytek uses its website (www.cytekbio.com), LinkedIn page and X account as channels of distribution of information about its company, products, planned financial and other announcements, attendance at upcoming investor and industry conferences and other matters. Such information may be deemed material information and Cytek may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Cytek’s website, LinkedIn page, and X account in addition to following its SEC filings, news releases, public conference calls and webcasts. Media Contact: Stephanie Olsen Lages &amp; Associates (949) 453-8080 stephanie@lages.com Investor Contact: Paul Goodson Head of Investor Relations Cytek Biosciences pgoodson@cytekbio.com <img alt="" src='https://ml.globenewswire.com/media/N2E0MTU3ZTctZmJhOC00ZDZjLWEzYTEtYzQ4MzAxYzI2ZGJjLTExMDczNTctMjAyNi0wNi0xMC1lbg==/tiny/Cytek-Biosciences-Inc-.png' referrerpolicy='no-referrer-when-downgrade' />

GlobeNewswire Inc.

Cytek Biosciences to participate at the Singular Research’s Las Vegas Invitational Conference

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn